Related references
Note: Only part of the references are listed.The Risk of Infections with Biologic Therapies for Rheumatoid Arthritis
Daniel E. Furst
SEMINARS IN ARTHRITIS AND RHEUMATISM (2010)
Etanercept therapy in rheumatoid arthritis and the risk of malignancies: a systematic review and individual patient data meta-analysis of randomised controlled trials
T. Bongartz et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
Translating Molecular Insights in Autoimmunity into Effective Therapy
Marc Feldmann
ANNUAL REVIEW OF IMMUNOLOGY (2009)
Risk of Tuberculosis Is Higher With Anti-Tumor Necrosis Factor Monoclonal Antibody Therapy Than With Soluble Tumor Necrosis Factor Receptor Therapy The Three-Year Prospective French Research Axed on Tolerance of Biotherapies Registry
F. Tubach et al.
ARTHRITIS AND RHEUMATISM (2009)
The vasculature in rheumatoid arthritis: cause or consequence?
Ewa M. Paleolog
INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY (2009)
Roles of the receptor tyrosine kinases Tie1 and Tie2 in mediating the effects of angiopoietin-1 on endothelial permeability and apoptosis
Christopher S. Milner et al.
MICROVASCULAR RESEARCH (2009)
Signal integration: a framework for understanding the efficacy of therapeutics targeting the human EGFR family
H. Michael Shepard et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Novel splice variants derived from the receptor tyrosine kinase superfamily are potential therapeutics for rheumatoid arthritis
Pei Jin et al.
ARTHRITIS RESEARCH & THERAPY (2008)
Regulated proteolytic processing of Tie1 modulates ligand responsiveness of the receptor-tyrosine kinase Tie2
Marie B. Marron et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Methionine aminopeptidase-2 blockade reduces chronic collagen-induced arthritis: potential role for angiogenesis inhibition
John Bainbridge et al.
ARTHRITIS RESEARCH & THERAPY (2007)
Emerging roles of the Angiopoietin-Tie and the ephrin-Eph systems as regulators of cell trafficking
Dennis Pfaff et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2006)
Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies - Systematic review and meta-analysis of rare harmful effects in randomized controlled trials
T Bongartz et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Vascular endothelial growth factor signalling in endothelial cell survival:: A role for NFκB
J Grosjean et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Gene therapy targeting the Tie2 function ameliorates collagen-induced arthritis and protects against bone destruction
Y Chen et al.
ARTHRITIS AND RHEUMATISM (2005)
Multiple angiopoietin recombinant proteins activate the Tie1 receptor tyrosine kinase and promote its interaction with Tie2
P Saharinen et al.
JOURNAL OF CELL BIOLOGY (2005)
Angiopoietin-like-4 is a potential angiogenic mediator in arthritis
LM Hermann et al.
CLINICAL IMMUNOLOGY (2005)
Akt is a major angiogenic mediator downstream of the Ang1/Tie2 signaling pathway
LM DeBusk et al.
EXPERIMENTAL CELL RESEARCH (2004)
Induction of tube formation by angiopoietin-1 in endothelial cell/fibroblast co-culture is dependent on endogenous VEGF
M Saito et al.
CANCER SCIENCE (2003)
Tie2 receptor tyrosine kinase, a major mediator of tumor necrosis factor α-induced angiogenesis in rheumatoid arthritis
LM DeBusk et al.
ARTHRITIS AND RHEUMATISM (2003)
Angiopoietin-1 is expressed in the synovium of patients with rheumatoid arthritis and is induced by tumour necrosis factor α
EM Gravallese et al.
ANNALS OF THE RHEUMATIC DISEASES (2003)
The angiogenesis inhibitor protease-activated kringles 1-5 reduces the severity of murine collagen-induced arthritis
PF Sumariwalla et al.
ARTHRITIS RESEARCH & THERAPY (2003)
DNA microarray analysis reveals novel gene expression profiles in collagen-induced arthritis
S Thornton et al.
CLINICAL IMMUNOLOGY (2002)
The endothelial receptor tyrosine kinase Tie1 activates phosphatidylinositol 3-kinase and Akt to inhibit apoptosis
CD Kontos et al.
MOLECULAR AND CELLULAR BIOLOGY (2002)
Angiostatin gene transfer as an effective treatment strategy in murine collagen-induced arthritis
JM Kim et al.
ARTHRITIS AND RHEUMATISM (2002)
Differential expression of the angiogenic Tie receptor family in arthritic and normal synovial tissue
S Shahrara et al.
ARTHRITIS RESEARCH (2002)
Biological action of angiopoietin-2 in a fibrin matrix model of angiogenesis is associated with activation of Tie2
K Teichert-Kuliszewska et al.
CARDIOVASCULAR RESEARCH (2001)
Evaluation of TNF-α and IL-1 blockade in collagen-induced arthritis and comparison with combined anti-TNF-α/anti-CD4 therapy
RO Williams et al.
JOURNAL OF IMMUNOLOGY (2000)
Evidence for heterotypic interaction between the receptor tyrosine kinases TIE-1 and TIE-2
MB Marron et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Immunohistochemical localisation of protein tyrosine kinase receptors Tie-1 and Tie-2 in synovial tissue of rheumatoid arthritis: correlation with angiogenesis and synovial proliferation
T Uchida et al.
ANNALS OF THE RHEUMATIC DISEASES (2000)
Angiopoietin-1 inhibits endothelial cell apoptosis via the Akt/survivin pathway
A Papapetropoulos et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Angiopoietin-1 regulates endothelial cell survival through the phosphatidylinositol 3'-kinase/Akt signal transduction pathway
I Kim et al.
CIRCULATION RESEARCH (2000)
Soluble cytokine receptors: novel immunotherapeutic agents
R Fernandez-Botran
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2000)
Share Paper
